Progenics Pharmaceuticals Inc. (PGNX)
NASDAQ: Health Care
$9.00
0.55 | 6.51%
0.55 | 6.51%
Today's Range:
8.61 -
9.25
PGNX Avg. Daily Volume:
126,000
05/29/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 8.45 |
| 52 Week High | 11.34 |
| 52 Week Low | 4.50 |
| Avg. Daily Vol. (Mil) | 0.13 |
| Beta (3 year) | 1.06 |
| Share Related Items | |
| Mkt Cap (Mil) | 286.13 |
| Shares Out (Mil) | 33.86 |
| Float (Mil) | 22.15 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 13.00 |
| Current Ratio | 13.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 14.30 |
| Price/Sales | 3.38 |
| Price/Book | 4.66 |
| Price/Cash Flow | 12.90 |
| Per Share Data | |
| Earnings | 0.59 |
| Sales | 2.50 |
| Book Value | 1.81 |
| Cash Flow | 0.66 |
| Business Summary | |
|---|---|
| Progenics Pharmaceuticals, Inc. is a biopharmaceutical company, which develops and commercializes innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. | |
| General Information | |
| 777 Old Saw Mill River Road
Tarrytown, NY 10591 |
|
| www.progenics.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 105 | |
| CEO: Mr. Mark R. Baker | |
| Short Interest | |
| Current Month (Mil) | 1.29 |
| Previous Month (Mil) | 1.30 |
| Short Interest Ratio (Days) | 8.50 |
| Management Effectiveness | |
| Return on Equity | 32.90 |
| Return on Assets | 30.20 |
| Return on Investments | 32.90 |
| Profitability | |
| Gross Margin | 99.40 |
| EBIT Margin | 23.90 |
| Profit Margin | 23.90 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.79
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet